|
Report Date : |
01.11.2012 |
IDENTIFICATION DETAILS
|
Name : |
PHARMA NOSTRA COMERCIAL LTDA |
|
|
|
|
|
|
Registered Office : |
Rua Aquidabã, 1144 - Lins De Vasconcelos 20720-294 - Rio De Janeiro/Rj |
|
|
|
|
|
|
Country : |
|
|
|
|
|
|
|
Financials (as on) : |
31.12.2010 |
|
|
|
|
|
|
Date of Incorporation : |
28.10.1999 |
|
|
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
|
|
Line of Business : |
Wholesale of Pharmaceuticals, Medical, Cosmetic and Chemical Products As Well As Reagents and Hemo-Derivatives. |
|
|
|
|
|
|
No. of Employees : |
Not Available |
|
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2011) |
Current Rating (30.06.2012) |
|
Brazil |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
BRAZIL - ECONOMIC OVERVIEW
Characterized by large and well-developed
agricultural, mining, manufacturing, and service sectors, Brazil's economy
outweighs that of all other South American countries, and Brazil is expanding
its presence in world markets. Since 2003, Brazil has steadily improved its
macroeconomic stability, building up foreign reserves, and reducing its debt
profile by shifting its debt burden toward real denominated and domestically
held instruments. In 2008, Brazil became a net external creditor and two
ratings agencies awarded investment grade status to its debt. After strong
growth in 2007 and 2008, the onset of the global financial crisis hit Brazil in
2008. Brazil experienced two quarters of recession, as global demand for
Brazil's commodity-based exports dwindled and external credit dried up.
However, Brazil was one of the first emerging markets to begin a recovery. In
2010, consumer and investor confidence revived and GDP growth reached 7.5%, the
highest growth rate in the past 25 years. Rising inflation led the authorities
to take measures to cool the economy; these actions and the deteriorating
international economic situation slowed growth to 2.7% for 2011 as a whole,
though forecasts for 2012 growth are somewhat higher. Despite slower growth in
2011, Brazil overtook the United Kingdom as the world's seventh largest economy
in terms of GDP. Urban unemployment is at the historic low of 4.7% (December
2011), and Brazil's traditionally high level of income equality has declined
for each of the last 12 years. Brazil's high interest rates make it an
attractive destination for foreign investors. Large capital inflows over the
past several years have contributed to the appreciation of the currency,
hurting the competitiveness of Brazilian manufacturing and leading the
government to intervene in foreign exchanges markets and raise taxes on some
foreign capital inflows. President Dilma ROUSSEFF has retained the previous
administration's commitment to inflation targeting by the central bank, a
floating exchange rate, and fiscal restraint.
Source : CIA
PHARMA NOSTRA
COMERCIAL LTDA
|
MAIN ADDRESS: |
RUA AQUIDABÃ, 1144 - LINS DE VASCONCELOS |
|
ZIP CODE/CITY: |
20720-294 - RIO DE JANEIRO/RJ |
|
|
|
|
PHONE: |
21 2141-1555 |
|
FAX: |
21 2141-1555 |
|
E-MAIL: |
thiago.silva@pharmanostra.com.br |
|
WEB SITE: |
www.pharmanostra.com.br |
|
BRANCHES: |
|
|
|
|
|
ADDRESS: |
VIA PRIMÁRIA 5D - QUADRA 10 MÓDULO 01 S/Nº. DAIA |
|
ZIP CODE/CITY: |
75133-600 ANÁPOLIS/GO |
|
PHONE: |
62 3316-5226 |
|
CNPJ: |
03.497.220/0002-41 |
|
|
|
|
ADDRESS: |
RUA ESTÁCIO DE SÁ, 530 - JARDIM SANTA GENEBRA |
|
ZIP CODE/CITY: |
13080-010 CAMPINAS/SP |
|
PHONE: |
19 2101-4000 |
|
CNPJ: |
03.497.220/0003-22 |
|
MAIN ACTIVITIES: |
|
WHOLESALE OF PHARMACEUTICALS, MEDICAL, COSMETIC AND CHEMICAL PRODUCTS
AS WELL AS REAGENTS AND HEMO-DERIVATIVES. |
|
LEGAL FORM: |
LIMITED
LIABILITY COMPANY |
|
|
|
|
INCORPORATION DATE: |
28/10/1999 |
|
REGISTER DATE: |
11/09/1999 |
|
BALANCE SHEET FILING DATE: |
31/12 |
|
TAX CONTRIBUTOR NUMBER(CNPJ): |
03.497.220/0001-60 |
|
STATE REGISTER: |
77.002.782 |
|
|
|
|
SHARE CAPITAL: |
R$ 1.200.000,00 |
|
LAST REGISTER OF CAPITAL: |
22/06/2007 |
|
BOARD OF
DIRECTORS: |
|
|
|
|
|
RAFAEL PADILHA PAPACEIT |
MANAGER |
|
IVAN JOSE MAROSTICA |
MANAGER |
|
THE MANAGERS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY. |
|
SHAREHOLDERS /
PARTNERS: |
|
|
|
|
|
FLAGRON EMPREENDIMENTOS E PARTICIPAÇÕES LTDA |
100% |
|
AFFILIATES /
SUBSIDIARIES: |
|
|
|
|
|
A SCAN THROUGH OUTSIDE SOURCES SHOWED THE SUBJECT AND/OR PARTNERS HAVE
THE FOLLOWING UNCONFIRMED HOLDINGS: |
|
|
|
|
|
SM EMPREENDIMENTOS FARMACÊUTICOS LTDA |
|
|
VIA FARMA IMPORTADORA LTDA |
|
|
TECABERABA PARTICIPAÇÕES LTDA |
|
|
LEAL & MAROSTICA REPRESENTAÇÕES COMERCIAIS LTDA |
|
|
THE SUBJECT WAS ESTABLISHED ON OCTOBER 28, 1999 TO BE ENGAGED IN THE
SAID LINE OF BUSINESS. TRADE NAME: "PHARMA NOSTRA". FURTHER DETAILS ARE SO FAR NOT KNOWN. WHEN INTERVIEWED SOURCES AT THE SUBJECT STATED THAT ARE STILL WAITING
FOR AUTHORIZATION FROM THE PRINCIPALS TO PROVIDE THE DATA NECESSARY TO
COMPLETE THIS REPORT. A REQUEST FOR FURTHER DATA HAS BEEN SENT TO THE COMPANY. PROVIDED THE
DATA REQUESTED ARE RECEIVED FROM THE SUBJECT A COMPLEMENTARY REPORT WILL BE
SENT TO YOUR ATTENTION. THE DATA CONTAINED HEREIN WERE OBTAINED FROM OUTSIDE SOURCES, OUR
DATABASE AND OFFICIAL. NO FURTHER DATA WAS AVAILABLE WITH SEVERAL SOURCES
USUALLY INVESTIGATED. |
|
PUBLIC RECORDS
INFORMATION: |
|
PROTESTS: |
|
5 PROTESTS,TOTAL AMOUNT R$
123.770,00 |
|
DETAILS OF LATEST PROTESTS: |
|
NOTARY OFFICE: |
DATE: |
VALUE: |
|
2º CARTÓRIO DE GO-ANÁPOLIS |
06/08/2012 |
R$ 46.000,00 |
|
1º CARTÓRIO DE GO-ANÁPOLIS |
06/08/2012 |
R$ 39.000,00 |
|
1º CARTÓRIO DE GO-ANÁPOLIS |
06/08/2012 |
R$ 30.000,00 |
|
1º CARTÓRIO DE GO-ANÁPOLIS |
17/07/2012 |
R$ 7.000,00 |
|
1º CARTÓRIO DE GO-ANÁPOLIS |
05/07/2012 |
R$ 1.770,00 |
|
LAWSUITS: |
|
|
|
|
DATE: |
COURT OF LAW: |
|
4 |
STATE LAWSUITS |
24/08/12 |
VARA DE SP-CAMPINAS |
|
GENERAL BALANCE SHEETS AS OF 31/12/2010, 31/12/2009 AND 31/12/2008. |
|
( FIGURES ARE IN THOUSANDS OF REAIS ). |
|
ASSETS |
|
|
|
|
CURRENT: |
31/12/2010 |
31/12/2009 |
31/12/2008 |
|
|
|
|
|
|
CASH AND BANKS |
3.952 |
3.055 |
462 |
|
INVESTMENTS |
2.088 |
1.681 |
1.160 |
|
CLIENTS |
16.998 |
14.707 |
17.255 |
|
INVENTORY |
14.381 |
11.053 |
18.719 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL CURRENT ASSETS |
37.419 |
30.496 |
37.596 |
|
LONG-TERM
RECEIVABLES: |
|
|
|
|
|
|
|
|
|
RECOVERABLE TAXES |
296 |
47 |
279 |
|
OTHER CREDITS |
4.873 |
1.057 |
77 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL LONG-TERM RECEIVABLES |
5.169 |
1.104 |
356 |
|
FIXED ASSETS: |
|
|
|
|
|
|
|
|
|
FIXED ASSETS |
11.637 |
10.486 |
9.974 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL FIXED ASSETS |
11.637 |
10.486 |
9.974 |
|
|
================ |
================ |
================ |
|
TOTAL ASSETS |
54.225 |
42.086 |
47.926 |
|
LIABILITIES: |
|
|
|
|
CURRENT: |
31/12/2010 |
31/12/2009 |
31/12/2008 |
|
|
|
|
|
|
SUPPLIERS |
11.000 |
8.095 |
11.324 |
|
LOANS AND FINANCING |
17.237 |
12.539 |
19.357 |
|
TAXES & CONTRIBUTIONS |
2.146 |
1.487 |
1.302 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL CURRENT LIABILITIES |
30.383 |
22.121 |
31.983 |
|
LONG TERM
LIABILITIES: |
|
|
|
|
|
|
|
|
|
TAXES AND CONTRIBUTIONS |
14.822 |
13.912 |
11.460 |
|
INSTALLMENTS TAXES PAYABLE |
609 |
728 |
1.043 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL LONG TERM LIABILITIES |
15.431 |
14.640 |
12.503 |
|
NET EQUITY: |
|
|
|
|
|
|
|
|
|
SHARE CAPITAL |
1.200 |
1.200 |
1.200 |
|
ACCRUED PROFIT (LOSS) |
4.125 |
2.240 |
1.860 |
|
PROFIT SHARING |
-3.990 |
-2.175 |
-1.839 |
|
PROFIT (LOSS) OF PERIOD |
7.076 |
4.060 |
2.219 |
|
|
---------------- |
---------------- |
---------------- |
|
TOTAL NET EQUITY |
8.411 |
5.325 |
3.440 |
|
|
================ |
================ |
================ |
|
TOTAL LIABILITIES |
54.225 |
42.086 |
47.926 |
|
PROFIT AND LOSS ACCOUNTS AS OF 31/12/2010, 31/12/2009 AND 31/12/2008. |
|
( FIGURES ARE IN THOUSANDS OF REAIS ). |
|
|
31/12/2010 |
31/12/2009 |
31/12/2008 |
|
|
|
|
|
|
GROSS SALES |
124.029 |
115.124 |
99.156 |
|
(-) TAXES ON SALES |
18.565 |
17.122 |
15.097 |
|
|
---------------- |
---------------- |
---------------- |
|
NET SALES |
105.464 |
98.002 |
84.059 |
|
(-) COST OF SOLD GOODS |
68.802 |
66.001 |
56.280 |
|
|
---------------- |
---------------- |
---------------- |
|
GROSS PROFIT |
36.662 |
32.001 |
27.779 |
|
OPERATING REVENUE (EXPENSE) |
-24.494 |
-22.277 |
-20.257 |
|
FINANCIAL REVENUE(EXPENSE) |
-5.460 |
-4.705 |
-5.577 |
|
|
---------------- |
---------------- |
---------------- |
|
OPERATIONAL PROFIT (LOSS) |
6.708 |
5.019 |
1.945 |
|
NON-OPERATING RESULT |
4.006 |
1.144 |
1.395 |
|
CONTRIBUTION/INCOME TAX |
-3.638 |
-2.103 |
-1.120 |
|
|
---------------- |
---------------- |
---------------- |
|
NET PROFIT (LOSS) |
7.076 |
4.060 |
2.220 |
|
RATIOS: |
31/12/2010 |
31/12/2009 |
31/12/2008 |
|
QUICK RATIO |
,76 |
|
,88 |
|
,59 |
|
|
CURRENT RATIO |
1,23 |
|
1,38 |
|
1,18 |
|
|
ACCOUNTS RECEIVABLE TURNOVER |
6,20 |
TIMES |
6,66 |
TIMES |
4,87 |
TIMES |
|
DAYS' SALES IN RECEIVABLES |
58,02 |
DAYS |
54,02 |
DAYS |
73,90 |
DAYS |
|
INVENTORY TURNOVER |
4,78 |
TIMES |
5,97 |
TIMES |
3,01 |
TIMES |
|
ACCOUNTS PAYABLE PERIOD |
57,56 |
DAYS |
44,15 |
DAYS |
72,44 |
DAYS |
|
RETURN ON ASSETS |
1,94 |
TIMES |
2,33 |
TIMES |
1,75 |
TIMES |
|
SALES TURNOVER ON NET EQUITY |
12,54 |
TIMES |
18,40 |
TIMES |
24,44 |
TIMES |
|
NET WORTH TIE-UP |
1,38 |
|
1,97 |
|
2,90 |
|
|
INDEBTEDNESS |
5,45 |
|
6,90 |
|
12,93 |
|
|
EQUITY RATIO |
15,51 |
% |
12,65 |
% |
7,18 |
% |
|
WORKING CAPITAL RATIO |
23,16 |
% |
37,86 |
% |
17,55 |
% |
|
GENERAL SOLVENCY |
1,18 |
|
1,14 |
|
1,08 |
|
|
RETURN ON NET EQUITY |
84,13 |
% |
76,24 |
% |
64,53 |
% |
|
RETURN ON SALES (PROFIT MARGIN) |
6,71 |
% |
4,14 |
% |
2,64 |
% |
|
GROSS PROFIT MARGIN |
34,76 |
% |
32,65 |
% |
33,05 |
% |
|
OPERATIONAL RESULT |
6,36 |
% |
5,12 |
% |
2,31 |
% |
|
SALES TURNOVER ON LIABILITIES |
3,47 |
TIMES |
4,43 |
TIMES |
2,63 |
TIMES |
|
FOREIGN CURRENCY ON ASSETS |
|
|
|
|
|
|
|
FOREIGN CURRENCY ON LIABILITIES |
|
|
|
|
|
|
|
EXCHANGE RATE: |
|
|
US$ 1,00 = R$ 2,03 |
- OFFICIAL RATE ON 30/10/2012 |
|
US$ 1,00 = R$ 1,66 |
- OFFICIAL RATE ON 31/12/2010 |
|
US$ 1,00 = R$ 1,74 |
- OFFICIAL RATE ON 31/12/2009 |
|
US$ 1,00 = R$ 2,33 |
- OFFICIAL RATE ON 31/12/2008 |
|
COMMENTS ON THE
FINANCIAL INFORMATION: |
|
FOLLOWS ATTACHED WORKSHEET WITH MAIN FINANCIAL RATIOS. THE FIGURES AVAILABLE SHOW A SATISFACTORY FINANCIAL STANDING. THE
LEVEL OF INDEBTEDNESS IS VERY HIGH AND MAINLY IS COMPRISED BY TRADE AND FINANCIAL
DEBTS BUT IT HAS GOOD CURRENT RATIO AND POSITIVE WORKING CAPITAL, CONSIDERED
SUFFICIENT TO COVER THE SHORT TERM DEBTS. IN ADDITION, IT SHOWS GROWING SALES
AND POSITIVE RESULTS. |
|
REAL ESTATE: |
THE PARTNERS OWN REAL ESTATE VALUED
AT R$ 940.000,00
|
DETAIL OF OWNED
REAL ESTATE: |
|
TYPE: |
OTHERS |
|
TOTAL AREA: |
9.600 SQ MTS |
|
VALUE: |
R$ 6.000.000,00 |
|
ADDRESS: |
PRIMÁRIA 5-D, QUADRA 10, MÓDULO 01, DAIA, ANÁPOLIS/GO |
|
REMARKS: |
BUILT UP AREA: 2.650 SQ MTS |
|
VEHICLES: |
OWNED VEHICLES ARE VALUED AT R$
34.195,59
|
MACHINES: |
OWNED MACHINES AND EQUIPMENTS
ARE VALUED AT R$ 78.807,05
|
SUBJECT IS ENGAGED IN THE WHOLESALE OF PHARMACEUTICALS, MEDICAL, COSMETIC
AND CHEMICAL PRODUCTS AS WELL AS REAGENTS AND HEMO-DERIVATIVES. |
|
|
BRANCH/PHONE: |
CITY: |
|
BANCO DO BRASIL S/A |
21 3150-3003 |
RIO DE JANEIRO/RJ |
|
BANCO ITAU S/A |
21 2544-2568 |
RIO DE JANEIRO/RJ |
|
BANCO SAFRA S/A |
21 2131-2300 |
RIO DE JANEIRO/RJ |
|
REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE
INFORMATION OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW
PROHIBITION WE ARE UNABLE TO PROVIDE ANY BANKING DETAILS. ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY
HAS NO RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682
BRAZILIAN CENTRAL BANK"). |
|
SUBJECT IS ENGAGED IN THE WHOLESALE OF PHARMACEUTICALS, MEDICAL, COSMETIC
AND CHEMICAL PRODUCTS AS WELL AS REAGENTS AND HEMO-DERIVATIVES. |
|
IMPORT AND
EXPORT: |
IMPORTS FROM:
|
CHINA, INDIA, GERMANY, ITALY, SWITZERLAND AND SPAIN. |
EXPORTS TO:
|
SWITZERLAND. |
|
MAIN CLIENTS: |
|
|
|
|
|
|
|
DOMESTIC CLIENTS: |
CITY: |
|
|
BELFAR LTDA |
BELO HORIZONTE/MG |
|
|
BULLA FARMA MANIPULAÇÃO LTDA |
PORTO ALEGRE/RS |
|
|
CIMED INDÚSTRIA DE MEDICAMENTOS LTDA |
SÃO PAULO/SP |
|
|
DROGADERMA LTDA |
SÃO PAULO/SP |
|
|
ELI E SU PROD. FARMACÊUTICOS LTDA |
GOIÂNIA/GO |
|
|
FARMACE IND. QUIM. FARMACÊUTICA CEARENSE LTDA |
BARBALHA/CE |
|
|
FARMACIA BELLAFARMA LTDA |
CAXIAS DO SUL/RS |
|
|
FARMACIA CENTER FORMULA LTDA |
SÃO PAULO/SP |
|
|
FARMACIA CENTRAL DE NOVA IGUAÇU LTDA |
NOVA IGUAÇU/RJ |
|
|
FARMÁCIA NEOATIVA LTDA |
BELO HORIZONTE/MG |
|
|
FARMACOPA FARM. LTDA |
RIO DE JANEIRO/RJ |
|
|
FUNDAÇÃO PARA O REMEDIO POPULAR - FURP |
SÃO PAULO/SP |
|
|
GEOLAB IND. FARMACÊUTICA LTDA |
ANÁPOLIS/GO |
|
|
GREGHI & PAIVA LTDA |
SANTOS/SP |
|
|
GUEDES & PAIXÃO LTDA |
MONTES CLAROS/MG |
|
|
HIPOLABOR FARMACÊUTICA LTDA |
BELO HORIZONTE/MG |
|
|
INSTITUTO DE TECNOLOGIA EM FÁRMACOS |
RIO DE JANEIRO/RJ |
|
|
LABORATÓRIO FARMACÊUTICO DO EST. PERNAMBUCO - LAFEPE |
RECIFE/PE |
|
|
LABORATÓRIO GLOBO LTDA |
SÃO JOSÉ DA LAPA/MG |
|
|
LABORATÓRIO QUIMICO E FARMACÊUTICO DO EXÉRCITO - LQFEX |
RIO DE JANEIRO/RJ |
|
|
MEDQUIMICA IND. FARMACÊUTICA LTDA |
JUIZ DE FORA/MG |
|
|
NATURE DERME PHARMÁCIA MANIPULAÇÃO LTDA |
BELO HORIZONTE/MG |
|
|
OLIVEIRA & CAVALCANTI LTDA |
BELO HORIZONTE/MG |
|
|
PHARLAB IND. FARMACÊUTICA LTDA |
LAGOA DA PRATA/MG |
|
|
PHARMÁCIA COM. E MANIP. FARM. LTDA |
GOIÂNIA/GO |
|
|
TOKARSKI COMÉRCIO E INDÚSTRIA LTDA |
GOIÂNIA/GO |
|
|
UNIVERSIDADE FEDERAL DO R. G. DO NORTE - NUPLAN |
NATAL/RN |
|
|
YUKIKO ETO & CIA LTDA |
SÃO JOSÉ DOS CAMPOS/SP |
|
|
STAFF: |
|
|
|
NOT AVAILABLE |
|
THE SUBJECT IS A WELL-ESTABLISHED COMPANY, OPERATING SINCE 1999. SO FAR
IT HAS A TRADE HISTORY AFFECTED BY SOME DETRIMENTAL FILES. THE COMPANY HAS TRADE RELATIONS WITH SEVERAL SUPPLIERS IN BRAZIL. THE
SUPPLIERS EXTEND CREDIT FACILITIES TO THE SUBJECT IN TERMS AND AMOUNTS
ACCORDING TO THE COMPANY'S NEEDS AND SO FAR NO PAYMENT PROBLEMS ARE NOTED. THE LAWSUITS REPORTED ARE NOT RELATED WITH TRADE DEBTS. THEY ARE
RELATED TO TAX DEBTS THAT FOR ANY REASON THE COMPANY HAS NOT YET PAID.
NEVERTHELESS WE POINT OUT THAT THE SAID LAWSUITS DO NOT AFFECT THE COMPANY'S
TRADE REPUTATION. OUR INVESTIGATION THROUGH THE PUBLIC RECORDS SHOWED SOME DETRIMENTAL
FILES REGISTERED AGAINST THE SUBJECT WHAT SHOWS IT HAS BEEN FAILING TO
FULFILL SOME OF ITS TRADE COMMITMENTS. HOWEVER, THOSE DETRIMENTAL FILES ARE
NOT CONSIDERED THAT RELEVANT IN RELATION TO THE COMPANY’S SCALE OF
ACTIVITIES. |
|
MAIN SUPPLIERS: |
|
|
|
|
|
|
|
DOMESTIC
SUPPLIERS: |
CITY: |
PHONE: |
|
CARDINAL HEALTH BRASIL 402 LTDA |
SOROCABA/SP |
15 3235-3500 |
|
GETEC GUANABARA QUIMICA IND. S/A |
SÃO GONÇALO/RJ |
21 2602-2000 |
|
IMPACTA INDÚSTRIA E COMÉRCIO |
CAJAMAR/SP |
11 4447-7300 |
|
MERCK S/A |
COTIA/SP |
11 4616-5431 |
|
TRADBOR IND. COMERCIO LTDA |
IPERÓ/SP |
15 3739-4909 |
|
FOREIGN
SUPPLIERS: |
COUNTRY: |
|
|
FERRO |
GERMANY |
|
|
GEMINI |
INDIA |
|
|
TIANJIN |
CHINA |
|
|
ZUHAI |
CHINA |
|
|
PAYMENT HISTORY: |
|
01 SUPPLIER REPORTED PAYMENTS: |
|
TOTAL AMOUNT: R$ 317,00 |
|
|
|
AMOUNT OF INVOICES PAID: 1 |
|
TOTAL OF PROMPT PAYMENTS: 100% |
|
HIGHEST INVOICE: R$ 317,00 |
|
HIGHEST CREDIT: R$ 317,00 |
|
THE SUBJECT HAS BEEN IN BUSINESS SINCE 1999. UP TO DATE IT HAS SOME
ADVERSE INFORMATION BUT IT HAS HIGH SCALE OF ACTIVITIES. BASED ON THE GENERAL INFORMATION AVAILABLE IT IS BELIEVED THAT GOOD TRADE
RELATIONS MAY BE ESTABLISHED. CREDIT FACILITIES MAY BE EXTENDED WITHIN TERMS
AND AMOUNTS ADEQUATE TO THE COMPANY'S FINANCIAL STRENGTH. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.12 |
|
|
1 |
Rs.87.07 |
|
Euro |
1 |
Rs.70.15 |
INFORMATION DETAILS
|
Report
Prepared by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.